Arbro Pharmaceuticals Private Limited - Company overview

Registered with ROC Delhi Ii on 28 June 1985, Arbro Pharmaceuticals is an active private limited company that has been around for more than …

1985-06-28 Na, Delhi Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹50–100 Cr
▲ 86.4%
FY 2023
PROFIT / LOSS
₹50 Lakh–1 Cr
▼ -5.8%
FY 2023
EBITDA
₹5–10 Cr
▼ -11.9%
FY 2023
NET WORTH
₹10–25 Cr
▲ 5.8%
FY 2023
TOTAL ASSETS
₹25–50 Cr
▲ 6.5%
FY 2023
EMPLOYEE COUNT
361–370
OPEN CHARGES
10
1.12 cr
PAID-UP CAPITAL
1.78 cr
AUTHORISED CAPITAL
1.99 cr
COMPANY AGE
41 Years 4 Months
since 1985-06-28
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
3
Updated: 2024-08-31 16:52:37
SATISFIED CHARGES
9
13.70 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Arbro Pharmaceuticals covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
86/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (68), financial health (95), director (95) and company-foundation signals.
  • Operating for 41+ years.
Compliance Score Moderate
68/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
95/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Arbro Pharmaceuticals Company identity, industry, contact, and registration details from MCA and company records.

Registered with ROC Delhi Ii on 28 June 1985, Arbro Pharmaceuticals is an active private limited company that has been around for more than 41 years. Its registered office is in Na, Delhi. It was earlier known as Arbro Pharmaceuticals Ltd..

Its filings describe the main line of business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 60.62% of turnover.

It has three directors: Sunil Kumar Jaitly, Saurabh Arora and Vijay Kumar Arora. The longest-serving is Vijay Kumar Arora, on the board since 1985; the most recent to join is Saurabh Arora, appointed in August 2005. Vijay Kumar Arora is the managing director. Three former directors are on record; the most recent to leave was Vinod Kumar Chhabra in May 2019.

Paid-up capital stands at ₹1.78 crore out of ₹1.99 crore authorised. The last AGM on record was on 30 September 2025, for accounts made up to 31 March 2025. Ten charges (secured loans) are still open, with Hdfc Bank Limited among the lenders, and nine more have been paid off.

Pharma •••••••• ••••••••
  • Location 6/14,Kirti Nagar Industrialarea,New Delhi, Na, Delhi
  • Website arbropharma.com
Name History
Legal NameArbro Pharmaceuticals Private Limited
CIN / LLPINU24232DL1985PTC021362
Company No.021362
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date1985-06-28
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Delhi Ii
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Arbro Pharmaceuticals (3) Current board members from MCA filings, including designation and appointment details.

S
Whole-time director | Since 1998-12-05 | DIN: 00555451
S
Director | Since 2005-08-05 | DIN: 00555403
V
Managing Director | Since 1985-06-28 | DIN: 00555040

Financial Performance of Arbro Pharmaceuticals Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹50–100 Cr ▲ 86.4%
P&L ₹50 Lakh–1 Cr ▼ -5.8%
EBITDA ₹5–10 Cr ▼ -11.9%
Net worth ₹10–25 Cr ▲ 5.8%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Arbro Pharmaceuticals Open and satisfied charges registered against the company with MCA.

Hdfc Bank Limited : 39.55 Lakh
Open Charges: 10 Satisfied Charges: 9
Open 1.12 cr
Satisfied 13.70 cr
LenderAmountStatus
Hdfc Bank Limited
Creation Date: 08 Jul 2025
7.98 Lakh Open
Hdfc Bank Limited
Creation Date: 08 Mar 2021
17.88 Lakh Open
Hdfc Bank Limited
Creation Date: 28 Aug 2020
5.21 Lakh Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products60.62
Professional, Scientific and TechnicalArchitecture, engineering activities, technical testing and analysis activities39.38

Financial Ratios of Arbro Pharmaceuticals Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Arbro Pharmaceuticals Ownership and contribution detail from filings. Full breakdown unlocks with your report.

8 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Arbro Pharmaceuticals EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Arbro Pharmaceuticals GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Arbro Pharmaceuticals Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Arbro Pharmaceuticals MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Arbro Pharmaceuticals Parent, subsidiary, and related group entities. Full ownership map unlocks with your report.

1 subsidiary on record

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

Parent company Subsidiaries and ownership Associates and joint ventures Entity investments

Corporate group structure requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Arbro Pharmaceuticals Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arbro Pharmaceuticals Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Arbro Pharmaceuticals?
MCA does not publish an "owner" field. Arbro Pharmaceuticals is run by its directors, Sunil Kumar Jaitly, Saurabh Arora and Vijay Kumar Arora, with Vijay Kumar Arora as managing director. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Arbro Pharmaceuticals?
Arbro Pharmaceuticals has three current directors: Sunil Kumar Jaitly (since December 1998), Saurabh Arora (since August 2005) and Vijay Kumar Arora (since June 1985). Vijay Kumar Arora is the managing director.
What is CIN of Arbro Pharmaceuticals?
The CIN of Arbro Pharmaceuticals is U24232DL1985PTC021362. Reading it left to right: U means it is not listed, 24232 is the industry code it registered under, DL is Delhi, 1985 is the year it was registered, PTC is the company type and 021362 is its registration number.
When was Arbro Pharmaceuticals incorporated?
Arbro Pharmaceuticals was incorporated on 28 June 1985 with ROC Delhi Ii. That makes it more than 41 years old.
What is the registered address of Arbro Pharmaceuticals?
The registered office on MCA records is 6/14, Kirti Nagar Industrialarea, New Delhi, Na, Delhi.
What is the current status of Arbro Pharmaceuticals?
MCA shows Arbro Pharmaceuticals as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Arbro Pharmaceuticals?
You can post to its registered office at 6/14, Kirti Nagar Industrialarea, New Delhi, Na, Delhi and use its website, https://arbropharma.com.
What industry or business activity is Arbro Pharmaceuticals associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (60.62% of turnover).
What is paid-up capital and authorised share capital of Arbro Pharmaceuticals?
Paid-up capital is ₹1.78 crore and authorised capital is ₹1.99 crore, so about 89% of the authorised amount has been issued.
When did Arbro Pharmaceuticals last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Arbro Pharmaceuticals?
Ten charges against Arbro Pharmaceuticals are still open and nine have been satisfied. Lenders named in the filings include Hdfc Bank Limited.
Have any directors left Arbro Pharmaceuticals?
Yes, three former directors are on record. The most recent to leave were Vinod Kumar Chhabra (May 2019), Promila Arora (November 2016) and Ram Avtar Singh (August 2009).
What is the turnover or revenue of Arbro Pharmaceuticals?
Based on filed financial statements, the revenue of Arbro Pharmaceuticals for FY 2023 was in the ₹50–100 Cr range. That is up 86.4% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Arbro Pharmaceuticals?
For FY 2023, the net worth of Arbro Pharmaceuticals was in the ₹10–25 Cr range.
How can I get the financial details of Arbro Pharmaceuticals?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Arbro Pharmaceuticals?
The website on record for Arbro Pharmaceuticals is https://arbropharma.com.
Which company owns arbropharma.com?
arbropharma.com is the website listed for Arbro Pharmaceuticals Private Limited in its company records.
Arbro Pharmaceuticals - is it listed or unlisted?
Arbro Pharmaceuticals is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Arbro Pharmaceuticals?
Arbro Pharmaceuticals is registered with ROC Delhi Ii.
What is the company classification of Arbro Pharmaceuticals?
MCA classifies Arbro Pharmaceuticals as: Private Limited Indian Non-Government Company.
Does Arbro Pharmaceuticals have subsidiaries?
Yes, one subsidiary is on record for Arbro Pharmaceuticals.
Does Arbro Pharmaceuticals have GST registrations on file?
Yes, 3 active GST registrations are linked to Arbro Pharmaceuticals, usually one per state it operates in.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.